FDA NDC Directory · JSON-LD · Markdown

Crenessity

NDC 70370-5100 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic namecrinecerfont
Labeler / ManufacturerNeurocrine Biosciences, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA218808
Dosage form / routeCAPSULE · ORAL
Active ingredientsCRINECERFONT (100 mg/1)
Marketing started20241213
Package count1

External sources

Source: openFDA. Public-domain (CC0).